Non-Hodgkin Lymphoma Treatment in Delhi

Non-Hodgkin lymphoma is a type of cancer that begins in the lymphatic system, which is part of the body’s immune system. The lymphatic system includes lymph nodes, the spleen, bone marrow, and lymph vessels, and it helps the body fight infections and maintain fluid balance. In non-Hodgkin lymphoma, certain white blood cells called lymphocytes grow and multiply in an abnormal and uncontrolled way.

As these abnormal lymphocytes accumulate, they can affect how the immune system functions and how the lymphatic system carries out its role in the body. Non-Hodgkin lymphoma is not a single disease but a broad group of related conditions that vary in how they develop and behave. Ongoing advances in medical understanding have helped improve knowledge of this condition, offering clearer information and reassurance to patients and their families.

Non-Hodgkin lymphoma (NHL) is not a single disease. It includes a group of blood cancers that differ in how they grow, how they affect the body, and how they are treated. Doctors classify non-Hodgkin lymphoma based on the type of lymphocyte involved and how quickly the cancer grows.

Based on the Type of Lymphocyte Involved

B-Cell Lymphomas

B-cell lymphomas are the most common type of non-Hodgkin lymphoma. They develop from B lymphocytes, which help the body fight infections by producing antibodies.

Common B-cell lymphomas include:

• Diffuse large B-cell lymphoma (DLBCL)
• Follicular lymphoma
• Mantle cell lymphoma
• Burkitt lymphoma
• Marginal zone lymphoma

Each type behaves differently, ranging from slow-growing to fast-growing forms.

T-Cell and NK-Cell Lymphomas

These lymphomas develop from T lymphocytes or natural killer (NK) cells, which play a role in immune defence and infection control. They are less common than B-cell lymphomas and can vary widely in severity.

Examples include:

• Peripheral T-cell lymphoma
• Anaplastic large cell lymphoma
• Cutaneous T-cell lymphoma

Based on How Fast the Lymphoma Grows

Indolent (Slow-Growing) Lymphomas

These lymphomas grow slowly and may not cause symptoms for a long time. Some patients may not need immediate treatment and are carefully monitored.

Examples include:

• Follicular lymphoma
• Small lymphocytic lymphoma

Aggressive (Fast-Growing) Lymphomas

These lymphomas grow quickly and usually require prompt treatment, but they often respond well to therapy.

Examples include:

• Diffuse large B-cell lymphoma
• Burkitt lymphoma

Why Identifying the Type Is Important

Understanding the exact type of non-Hodgkin lymphoma helps doctors:

• Choose the most effective treatment plan
• Estimate how the disease may behave
• Decide how urgently treatment is needed

Each type of non-Hodgkin lymphoma is treated differently, which is why accurate diagnosis and classification are essential.

Non-Hodgkin lymphoma develops when certain white blood cells, known as lymphocytes, begin to grow and multiply abnormally. These changes usually affect the immune system’s ability to function properly. While the exact cause is not always clear, several underlying factors are believed to play a role. Here are the main causes of non-Hodgkin lymphoma.

Genetic Changes in Lymphocytes

Non-Hodgkin lymphoma often begins due to changes in the DNA of lymphocytes. These changes interfere with normal cell growth and division, leading to the accumulation of abnormal cells in lymph nodes or other organs.

Weakened Immune System Function

When the immune system is not working as it should, it may fail to regulate lymphocyte growth properly. This imbalance can contribute to the development of lymphoma over time.

Chronic Immune Stimulation

Long-standing immune activation, where the immune system is repeatedly triggered, can increase the likelihood of abnormal lymphocyte behaviour and cancerous changes.

Certain Infections

Some viral or bacterial infections can affect how lymphocytes function. In a small number of cases, these infections may contribute to abnormal immune responses linked to lymphoma development.

Non-Hodgkin lymphoma can affect people of all ages, but certain factors may increase the likelihood of developing the condition. Understanding these risks helps patients and families recognise vulnerability and seek timely medical evaluation. Here are the key risk factors for non-Hodgkin lymphoma.

Increasing Age

The risk of non-Hodgkin lymphoma rises with age, with most cases diagnosed in adults over 60, although it can also occur in younger individuals and children.

Weakened Immune System

People with conditions that suppress the immune system, or those taking long-term immune-suppressing medications, may be more vulnerable to lymphoma.

Autoimmune Disorders

Certain autoimmune conditions, where the immune system attacks healthy tissues, can increase the risk due to ongoing immune system activation.

Exposure to Certain Chemicals

Long-term exposure to specific chemicals, such as pesticides or industrial solvents, may slightly increase the risk in some individuals.

Family History of Lymphatic Cancers

Having a close family member with lymphoma or other blood cancers may increase susceptibility, although most cases occur without a family history.

Non-Hodgkin lymphoma (NHL) can produce a wide variety of symptoms depending on where the lymphoma develops in the body and how aggressive the cancer is. Some people experience noticeable symptoms early on, while others may have no symptoms at all in the early stages, with the disease discovered incidentally during routine medical examinations.

General Symptoms

The most common initial sign of non-Hodgkin lymphoma is painless swelling of the lymph nodes in the neck, armpits, or groin. These feel like firm, rubbery lumps under the skin that don't go away like typical infection-related swelling.

Many patients also experience "B symptoms," which include:

• Unexplained fever
• Drenching night sweats
• Unintentional weight loss (more than 10% of body weight over six months)
• Persistent fatigue

Location-Specific Symptoms

Symptoms vary based on where the lymphoma develops in the body:

• Chest: Persistent cough, shortness of breath, chest pain
• Abdomen: Abdominal pain or swelling, feeling full quickly, digestive changes
• Brain/Spinal cord:Headaches, vision problems, neurological changes
• Skin: Itchy lumps or patches
• Bone marrow: Anemia, frequent infections, easy bruising

Other Common Symptoms

• Persistent itching all over the body
• Loss of appetite
• Enlarged spleen or liver
• Recurrent infections

Many of these symptoms can be caused by conditions far more common than lymphoma. However, persistent, unexplained symptoms—particularly painless lymph node swelling lasting more than two weeks, or the combination of fever, night sweats, and weight loss—should prompt evaluation by a healthcare provider.

Diagnosing non-Hodgkin lymphoma requires a careful and systematic approach, as symptoms can vary widely depending on the type and stage of the disease. An accurate diagnosis helps determine the specific lymphoma subtype and guides the most appropriate treatment plan. At Max Hospitals, doctors follow a structured evaluation process combining clinical assessment, laboratory investigations, imaging, and tissue analysis to ensure clarity and timely care.

Initial Clinical Evaluation

The diagnostic process begins with a detailed review of symptoms, medical history, and overall health. Doctors assess signs such as painless swelling of lymph nodes in the neck, armpits, or groin, unexplained fever, night sweats, weight loss, fatigue, or persistent infections. A physical examination focuses on lymph nodes, spleen, liver, and other areas where lymphoma may be present.

Laboratory Tests

Blood tests support the diagnostic evaluation and help assess overall health:

• Complete blood count (CBC): Checks for abnormalities in red blood cells, white blood cells, and platelets, which may indicate bone marrow involvement.
• Blood chemistry tests: Assess kidney and liver function and detect metabolic changes associated with lymphoma.
• Lactate dehydrogenase (LDH): Elevated levels may indicate a higher tumour burden or more aggressive disease.
• Viral screening: Tests for infections such as hepatitis or HIV, which may influence treatment planning.

Imaging Studies

Imaging plays an important role in identifying disease extent and affected areas:

• CT scan: Helps detect enlarged lymph nodes and involvement of organs such as the chest, abdomen, or pelvis.
• PET-CT scan: Combines metabolic and anatomical imaging to assess disease activity, guide staging, and evaluate treatment response.
• MRI: May be used in selected cases, particularly when the brain, spinal cord, or specific organs are involved.

Lymph Node Biopsy

A biopsy is essential to confirm the diagnosis of non-Hodgkin lymphoma:

• Excisional or core biopsy: A lymph node or tissue sample is removed and examined under a microscope to identify lymphoma cells and determine the exact subtype.
• Pathological analysis: Special tests, including immunohistochemistry and genetic studies, help classify the lymphoma and assess its behaviour.

Bone Marrow Examination

A bone marrow aspiration and biopsy may be performed to determine whether the lymphoma has spread to the bone marrow. This information is important for staging and treatment planning.

Staging and Further Assessment

Once non-Hodgkin lymphoma is confirmed, additional tests are carried out to determine the stage of the disease. Staging considers how many lymph node regions are involved, whether organs outside the lymphatic system are affected, and the overall spread of the disease. Accurate staging allows doctors to develop an individualised treatment plan.

Treatment for non-Hodgkin lymphoma depends on whether the lymphoma is slow-growing (indolent) or fast-growing (aggressive), the extent of disease spread, involvement of organs such as bone marrow or spleen, and the presence of symptoms. 

While some patients may require immediate treatment, others with early-stage or slow-growing disease may be closely monitored before therapy begins. At Max Hospitals, care is delivered through a coordinated, multidisciplinary approach to ensure effective disease control while maintaining quality of life.

Chemotherapy

Chemotherapy forms the backbone of treatment for many types of non-Hodgkin lymphoma and may be used alone or in combination with other therapies.

Chemotherapy involves the use of anti-cancer drugs to destroy lymphoma cells throughout the body. Treatment is usually given in cycles, allowing the body time to recover between sessions. The choice of drugs and duration of treatment depend on the lymphoma subtype and stage. Doctors closely monitor response and adjust treatment if needed to balance effectiveness and side effects.

Immunotherapy

Immunotherapy uses medicines that help the body’s immune system recognise and target lymphoma cells more effectively.

Monoclonal antibodies are commonly used in non-Hodgkin lymphoma and are often combined with chemotherapy to improve outcomes. These treatments specifically target proteins found on lymphoma cells, helping to destroy them while limiting damage to healthy cells.

Targeted Therapy

Targeted therapies act on specific molecules involved in the growth and survival of lymphoma cells.

These treatments may be recommended for certain subtypes of non-Hodgkin lymphoma or when the disease does not respond to standard chemotherapy. Targeted therapies can help control the disease with a different side-effect profile compared to traditional chemotherapy.

Radiation Therapy

Radiotherapy may be used in selected cases, particularly for early-stage disease or to treat lymphoma confined to a specific area.

High-energy radiation is directed at affected lymph nodes or organs to destroy cancer cells. Radiotherapy may also be used to relieve symptoms such as pain or pressure caused by enlarged lymph nodes.

Stem Cell Transplant

A stem cell transplant may be considered for patients with recurrent or high-risk lymphoma.

This treatment involves using high-dose chemotherapy to destroy lymphoma cells, followed by infusion of healthy stem cells to restore bone marrow function. Stem cell transplantation is recommended only in carefully selected patients and requires specialised care and close monitoring.

Supportive Care

Supportive care is an essential part of non-Hodgkin lymphoma treatment, helping patients manage treatment-related side effects and maintain overall wellbeing. This may include:

• Management of infections and low immunity
• Blood transfusions when required
• Medications to reduce nausea, pain, or fatigue
• Nutritional support and dietary advice
• Psychological and emotional support for patients and families

Follow-Up and Monitoring

After treatment, regular follow-up is important to assess response, detect relapse early, and manage long-term effects of therapy. Follow-up may include physical examinations, blood tests, imaging studies, and ongoing assessment of quality of life. Long-term monitoring helps ensure timely intervention if the disease returns or complications arise.

Treatment for non-Hodgkin lymphoma involves close collaboration between haematologists, medical oncologists, radiation oncologists, pathologists, radiologists, nurses, and supportive care specialists. This multidisciplinary approach ensures that each patient receives coordinated, personalised care from diagnosis through treatment and long-term follow-up.

If non-Hodgkin lymphoma is not diagnosed early or does not respond adequately to treatment, it may lead to several complications affecting overall health and daily functioning.

Progressive Lymph Node Enlargement

Enlarged lymph nodes may continue to grow, causing discomfort, pressure on nearby organs, or visible swelling in the neck, armpits, or groin.

Weakened Immune System

The disease and its treatment can impair immune function, increasing vulnerability to infections and delaying recovery from common illnesses.

Bone Marrow Involvement

When lymphoma affects the bone marrow, it may interfere with normal blood cell production, leading to anaemia, easy bruising, or increased risk of infection.

Organ Involvement

Spread to organs such as the liver, spleen, lungs, or gastrointestinal tract may disrupt their normal function and cause additional symptoms.

Fatigue and Weight Loss

Ongoing disease activity may result in persistent tiredness, reduced appetite, and unintentional weight loss.

Treatment-Related Complications

Certain therapies may cause side effects such as nausea, hair loss, nerve symptoms, or long-term health concerns that require monitoring.

Early diagnosis, timely treatment, and regular follow-up significantly reduce the risk of complications and support better long-term outcomes.

While non-Hodgkin lymphoma cannot always be prevented, certain measures help lower risk factors where possible and support early detection.

Awareness of Persistent Symptoms

Unexplained lymph node swelling, prolonged fever, night sweats, or unexplained weight loss should be evaluated promptly.

Managing Immune-Related Conditions

Proper management of immune disorders and chronic infections may help reduce associated risks.

Avoiding Known Risk Exposures

Limiting exposure to harmful chemicals or unnecessary radiation supports long-term health.

Regular Medical Check-ups

Routine health evaluations may help identify abnormalities early, especially in individuals with higher risk profiles.

Adherence to Follow-up Care

For those previously treated for lymphoma or related conditions, structured follow-up supports early detection of recurrence or complications.

Prevention focuses on symptom awareness, timely medical evaluation, and proactive health monitoring to support early diagnosis and effective care.

Is non-Hodgkin lymphoma contagious?

No, non-Hodgkin lymphoma is not contagious. It cannot spread from one person to another through physical contact, shared food, or close living conditions.

Can non-Hodgkin lymphoma affect daily life even during remission?

Some people may experience lingering fatigue, reduced stamina, or emotional stress even after treatment ends. Regular follow-up and gradual lifestyle adjustments often help restore routine activities over time.

Is non-Hodgkin lymphoma considered curable?

Outcomes vary by subtype and stage. Many aggressive forms respond very well to treatment and can be cured, while some slow-growing types are managed as long-term conditions with periods of remission.

How does non-Hodgkin lymphoma impact work and professional life?

The impact differs between individuals. Some people continue working during treatment with adjustments, while others may need time off due to fatigue or side effects. Employers are often able to support flexible arrangements.

Can non-Hodgkin lymphoma return after successful treatment?

Yes, relapse can occur in some cases, which is why long-term monitoring is important. Early detection of recurrence allows timely intervention and effective management.

Are there dietary restrictions for people with non-Hodgkin lymphoma?

There is no single lymphoma-specific diet. A balanced, nutritious diet helps maintain strength and immunity, and dietary advice may be personalised during or after treatment.

Does non-Hodgkin lymphoma affect fertility?

Certain treatments may impact fertility, depending on age and therapy type. Fertility preservation options can be discussed before starting treatment when appropriate.

Is it safe to travel after being diagnosed with non-Hodgkin lymphoma?

Travel is often possible, but plans should be discussed with the treating doctor, especially during active treatment or if immunity is low.

Can non-Hodgkin lymphoma occur during pregnancy?

Although uncommon, it can occur. Management requires careful coordination between cancer specialists and obstetricians to protect both mother and baby.

Are vaccinations safe for people with non-Hodgkin lymphoma?

Some vaccines are recommended, while others—especially live vaccines—may not be suitable. Vaccination decisions should always be guided by the treating doctor.

Should patients seek a second opinion for non-Hodgkin lymphoma?

A second opinion can help patients feel confident about their diagnosis and treatment plan, particularly for rare subtypes or complex cases.

How long does follow-up continue after treatment is completed?

Follow-up typically continues for several years and may be lifelong. Regular visits help monitor recovery, detect relapse early, and manage long-term effects of treatment.

Reviewed by Dr Ankit Kumar, Senior Consultant – Haemato-Oncology and Bone Marrow Transplant, Cancer Care / Oncology, Haematology, on 24 March 2026.